LEE DIONNE: Open Payments
NPI 1104472679 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,921 in 74 payments from 16 companies in 2025. Trend: 2023 $1,920 · 2024 $1,909 · 2025 $1,921
Food & beverage: $1,771Education: $150
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $381 |
| E.R. Squibb & Sons, L.L.C. | 5 | $280 |
| GENZYME CORPORATION | 8 | $220 |
| ABBVIE INC. | 12 | $190 |
| Organon LLC | 6 | $150 |
| Janssen Biotech, Inc. | 4 | $125 |
| UCB, Inc. | 4 | $115 |
| PFIZER INC. | 1 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
Products named: NEMLUVIO, DUPIXENT, Sotyktu, TREMFYA, Bimzelx, VTAMA, LITFULO, SKYRIZI.
Industry payments across CO — which companies pay providers there.
